A trial HIV vaccine helps to produce those elusive but crucial antibodies, paving the path for a vaccine that works.

Published Date: 22 May 2024

A small number of individuals participating in a 2019 clinical trial had low levels of an elusive type of broadly neutralizing HIV antibodies in response to an HIV vaccine candidate developed at the Duke Human Vaccine Institute.

Read Full News

Todays Updates


5 Psychiatry Headlines You Missed in September 2026


5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH


An updated open-label extension analysis and new MRI data from the phase 3 EPIDYS trial, presented at the 2026 AANEM Annual Meeting, add to the evidence for givinostat's long-term effects on disease progression.

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio


A new Bayesian network meta-analysis found nipocalimab's serious adverse event rates compared favorably with other gMG therapies, while overall adverse event rates were comparable.

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio


New data from a Cure SMA survey showed that children treated with disease-modifying therapy soon after birth walk more often and have fewer comorbidities than those treated later.

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of MDS!

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis


Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD


Friedman outlines how dermatologists can track cumulative corticosteroid exposure, identify at-risk patients, and improve patient adherence with handouts.

Todays Updates


5 Psychiatry Headlines You Missed in September 2026


5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH


An updated open-label extension analysis and new MRI data from the phase 3 EPIDYS trial, presented at the 2026 AANEM Annual Meeting, add to the evidence for givinostat's long-term effects on disease progression.

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio


A new Bayesian network meta-analysis found nipocalimab's serious adverse event rates compared favorably with other gMG therapies, while overall adverse event rates were comparable.

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio


New data from a Cure SMA survey showed that children treated with disease-modifying therapy soon after birth walk more often and have fewer comorbidities than those treated later.

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of MDS!

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis


Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD


Friedman outlines how dermatologists can track cumulative corticosteroid exposure, identify at-risk patients, and improve patient adherence with handouts.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

2.

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

5.

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot